The pharmacy workforce is not suffering from a shortage of talent. It is constrained by systems that were never built to use that talent in the first place fully.
Over the past five years, governments, regulators, and professional bodies have invested heavily in expanding pharmacists’ roles. They have pushed for prescriptive authority, advanced credentials, and integration into primary care teams. But roles without infrastructure are just upgraded job descriptions. If the system is not designed to sustain, fund, and govern those roles, it stalls on contact with reality. A pharmacist granted prescribing authority but given no protected time, no billing code, or no strategic voice has been set up to fail.
That is the problem. And that is where real reform has to begin.
Role Expansion Isn’t Structural Reform
Globally, pharmacist roles have expanded faster than the systems meant to support them. The World Health Organization and the International Pharmaceutical Federation have both called for pharmacy to evolve from a transactional supply function into a clinical, system-integrated discipline [1, 2]. The United Kingdom’s National Health Service has gone further than most, mandating that all new pharmacists qualify as independent prescribers from the point of registration by 2026 [3].
But here is the lesson. New titles do not deliver value. New systems do.
The American Pharmacists Association has spent years pushing for provider status through federal legislation [4]. Meanwhile, U.S. states have expanded pharmacists’ authority to test, treat, vaccinate, and prescribe under collaborative agreements [5]. These changes matter, but without matching changes in governance, funding, and performance metrics, expanded scope often leads to burnout, role confusion, or administrative overload.
Designing for Function, Not Permission
A reformed pharmacy workforce must be structurally integrated, not just clinically upskilled. That means:
- Aligned education and deployment: What pharmacists are trained to do must match what the system funds and expects. Countries like the UK and Qatar are leading this alignment by redesigning pharmacy education to produce system-ready clinicians, not dispensers with inflated titles.
- Governance structures that assign accountability: Pharmacists cannot lead change if governance structures treat them as support staff. Workforce reform requires formalized leadership, integration into multidisciplinary governance, and access to operational levers, not just clinical handoffs.
- Defined value channels: Pharmacists add measurable value in medication safety, chronic disease management, and public health, but only if the system tracks those outcomes. Without visibility into impact, even high-performing teams remain peripheral.
What Structural Reform Actually Looks Like
We are now seeing countries move from role inflation to system redesign. Saudi Arabia has driven the mandatory integration of clinical pharmacists into all public hospitals as a cornerstone of its health system transformation [6]. Qatar restructured its national PharmD curriculum and built hospital workflows around pharmacist-led medication management [7]. The UK linked pharmacy integration directly to its national workforce strategy and created credentialing pathways for advanced and consultant pharmacists [8, 9]. These are three traits they share; they are not merely projects but rather fundamental shifts.
- Aligned financing and regulation: Pharmacists’ clinical services are both legally authorized and sustainably funded, moving beyond product-based reimbursement.
- Integrated governance: Pharmacists have a formal seat at the table where system strategy, resource allocation, and care standards are set.
- Defined career architecture: Advanced practice pathways are explicitly tied to system needs, validated competencies, and measurable outcomes, not just individual ambition.
These structures anchor pharmacists in healthcare, not as extensions of other roles but as distinct contributors with defined accountabilities.
A System Designed to Retain and Evolve
Reform is not just about activating talent. It is about retaining it under pressure.
APhA, ASHP, and NABP have jointly called out unsustainable working conditions and structural attrition in U.S. pharmacy [10]. Their collaboration on the Pharmacy Workplace and Well-Being Reporting system underscores a critical reality: scope expansion without operational redesign is a formula for burnout.
In response, institutions are testing system-level safeguards, including workload caps, pharmacy-to-technician ratios, protected clinical time, and funding for new primary care roles.
Reframing the Work Ahead
Pharmacy workforce reform must shift its core question from: “What more can pharmacists do?” to: “What systems must we build to make their work sustainable and measurable?”
At Veridian House, this is our core focus. We do not chase new credentials for the profession. We build the operational structures in governance, education, financing, and system architecture that turn clinical competence into lasting impact. The pharmacy profession already has the skills. What it needs now is a deliberately designed framework to apply them.
From the Author
This perspective comes from direct work across systems that claim to value pharmacy yet are structurally unequipped to support it. I have watched clinical excellence fail to scale because of operational barriers, seen workforce policy drafted without input from the workforce itself, and reviewed reform agendas that deliberately avoided tackling governance. Veridian House was created to bridge that gap, not with rhetoric, but with executable frameworks. Tell us, where have you seen real pharmacy workforce reform in your country? What has worked, what has not, and what is still missing? We welcome perspectives from every system, especially those pushing the boundaries.
Dr. Danya Almheiri
Redesign Your Pharmacy Workforce From the System Up
To discuss how your institution can align workforce design with system strategy, contact info@veridian-house.com
Reference List
[1] World Health Organization. (2019). Building pharmacy workforce capacity. https://www.who.int/publications/i/item/building-pharmacy-workforce-capacity
[2] International Pharmaceutical Federation. (2021). Pharmacy Workforce Transformation. https://www.fip.org/fip-development-goals
[3] General Pharmaceutical Council. (2022). Independent prescribing for all pharmacists. https://www.pharmacyregulation.org
[4] American Pharmacists Association. (2024). Provider Status. https://www.pharmacist.com/Advocacy/Provider-Status
[5] National Alliance of State Pharmacy Associations. (2024). https://naspa.us/
[6] Saudi Commission for Health Specialties. (2023). https://www.scfhs.org.sa/
[7] Kheir, N., & Zaidan, M. (2019). Pharmaceutical care in Qatar. https://apps.who.int/iris/handle/10665/325868
[8] NHS England. (2023). NHS Long Term Workforce Plan. https://www.england.nhs.uk/publication/nhs-long-term-workforce-plan/
[9] Royal Pharmaceutical Society. (2023). Advanced Practice Framework. https://www.rpharms.com
[10] ASHP. (2023). Joint Policy Statement on Pharmacy Workplace Issues. https://www.ashp.org
